Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled study
PaperCitations, authors & open-access status
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 211 citations, 2014 year and hybrid oa status.
211
Citations
2014
Year
hybrid
OA Status